Back

Circulating levels of ST2 are associated with myocardial injury, left ventricular function and future adverse clinical events in patients with ST-elevation myocardial infarction.

1 September 2019 (15:26 - 15:40)
Organised by:
Congress Presentation Part of: Non-troponin biomarkers in acute coronary syndromes Inflammation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Jan Eritsland

Oslo University Hospital Ulleval, Oslo (Norway)

4 More presentations in this session

Presentation thumbnail
Circulating serum extracellular matrix degradation enzyme cathepsin S predicts mortality and improves risk stratification over the GRACE score in patients with non-ST elevation acute coronary syndrom
Doctor K. Sopova (Mannheim, DE)
Abstract
Presentation thumbnail
Apoptotic and non-apoptotic circulating microparticles in patients with acute coronary syndromes
Doctor A. Antonopoulos (Athens, GR)
Abstract
Presentation thumbnail
Results from the CAMI1 Study: Selective CRP apheresis as a new treatment option in acute myocardial infarction
Professor C. Garlichs (Flensburg, DE)
Abstract
Presentation thumbnail
HsCRP predicts mortality beyond troponin in 102,337 patients with suspected acute coronary syndrome (CRP-RISK study)
Doctor A. Kaura (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Non-troponin biomarkers in acute coronary syndromes

The Event

Event poster

ESC Congress 2019

1 September 2019 15:26 CET